crazyleaf gip/glp-1 GIP And GLP-1 Monthly Weight Loss Program Oral Semaglutide, the First Ingestible

Novo Nordisk has launched the Medicare GLP-1 Bridge, making Wegovy available to eligible Medicare beneficiaries for $50 a month through the end of 2027, giving millions of older adults with obesity a structured pathway to the FDA-approved weight management drug

10.1289/ehp11813

A luminescent biosensor with increased dynamic range for intracellular cAMP

Injecting MTX into carnitine-depleted rats achieved 66% and 99.5% elevation in serum ALT and AST, respectively, compared with the control, and 34% elevation compared with the MTX group

10.1111/j.1463-1326.2007.00692.x

Clinical data shows that patients on stable levothyroxine doses rarely experience significant thyroid dysfunction when starting GLP-1 therapy